High-dose flu vaccine linked to fewer hospitalisations than standard dose in older adults with lung disease
Pooled data from two randomised trials presented at ERS 2026 point to fewer flu and pneumonia hospitalisations with high-dose vaccine in adults aged 65 and over with lung disease.